Patents by Inventor Sabine MAZALEYRAT

Sabine MAZALEYRAT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11261438
    Abstract: Described are mevalonate diphosphate decarboxylase variants having improved activity in converting 3-phosphonoxyisovalerate into isobutene. Such variants can be employed in processes for biologically producing isobutene from 3-hydroxyisovalerate or from 3-hydroxy-3-methylbutyrate into isobutene, for biologically producing isoprenol from mevalonate or from mevalonate-3-phosphate or for biologically producing 1,3-butadiene from 3-hydroxypent-4-enoate or from 3-phosphonoxypent-4-enoate. Also described is an enzyme which is characterized in that it is capable of converting 3-phosphonoxyisovalerate into isobutene with a kcat of more than 0.1 s?1.
    Type: Grant
    Filed: July 9, 2014
    Date of Patent: March 1, 2022
    Assignees: Global Bioenergies, Scientist of Fortune, S.A.
    Inventors: Sabine Mazaleyrat, Marc Delcourt, Maria Anissimova, Philippe Marliere
  • Patent number: 10407669
    Abstract: Described are HIV kinase variants showing an improved activity in converting 3-hydroxyisovalerate (HIV) into 3-phosphonoxyisovalerate (PIV), methods for the production of PIV using such enzyme variants as well as methods for the production isobutene in a subsequent reaction.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: September 10, 2019
    Assignees: Global Bioenergies, Scientist of Fortune, S.A.
    Inventors: Sabine Mazaleyrat, Jean-Baptiste Barbaroux, Marc Delcourt, Francois Stricher, Philippe Marlière
  • Patent number: 10364418
    Abstract: Described are 3-hydroxyisovalerate (HIV) synthase variants having improved activity in converting acetone and a compound which provides an activated acetyl group into 3-hydroxyisovalerate (HIV). Moreover, described are in particular methods for the production of 3-hydroxyisovalerate and methods for the production of isobutene from acetone utilizing the HIV synthase variants of the present invention.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: July 30, 2019
    Assignees: Global Bioenergies, Scientist of Fortune, S.A.
    Inventors: Philippe Marliére, Marc Delcourt, Sabine Mazaleyrat, Jean-Baptiste Barbaroux
  • Patent number: 10113186
    Abstract: Described are alkenol dehydratase variants having improved activity in catalyzing the conversion of prenol into isoprene, methods for the production of isoprene using such enzyme variants and their uses in the production of isoprene from prenol.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: October 30, 2018
    Assignees: Global Bioenergies, Scientist of Fortune, S.A.
    Inventors: Sabine Mazaleyrat, Marc Delcourt, Philippe Marlière
  • Publication number: 20180223266
    Abstract: Described are HIV kinase variants showing an improved activity in converting 3-hydroxyisovalerate (HIV) into 3-phosphonoxyisovalerate (PIV), methods for the production of PIV using such enzyme variants as well as methods for the production isobutene in a subsequent reaction.
    Type: Application
    Filed: July 27, 2016
    Publication date: August 9, 2018
    Applicants: Global Bioenergies, Scientist of Fortune, S.A.
    Inventors: Sabine Mazaleyrat, Jean-Baptiste Barbaroux, Marc Delcourt, Francois Stricher, Philippe Marlière
  • Patent number: 10036003
    Abstract: Described are alkenol dehydratase variants having improved activity in catalyzing the conversion of a compound corresponding to the general formula CnH2nO into CnH2n-2 +H2O with 3<n<7. In particular, described are alkenol dehydratase variants having, e.g., an improved activity in converting but-2-en-1-ol (crotyl alcohol) into 1,3 butadiene and/or an improved activity in converting but-3-en-2-ol into 1,3 butadiene and/or an improved activity in converting 3-methylbut-2-en-1-ol (prenol) or 3-methylbut-3-en-2-ol (isoprenol) into isoprene and/or an improved activity in converting 2,3-dimethyl-but-2-en-1-ol into dimethyl-butadiene.
    Type: Grant
    Filed: May 16, 2014
    Date of Patent: July 31, 2018
    Assignees: Global Bioenergies, Scientist of Fortune, S.A.
    Inventors: Philippe Marliere, Marc Delcourt, Sabine Mazaleyrat
  • Publication number: 20170321229
    Abstract: Described are alkenol dehydratase variants having improved activity in catalyzing the conversion of prenol into isoprene, methods for the production of isoprene using such enzyme variants and their uses in the production of isoprene from prenol.
    Type: Application
    Filed: November 12, 2015
    Publication date: November 9, 2017
    Applicants: Global Bioenergies, Scientist of Fortune, S.A.
    Inventors: Sabine MAZALEYRAT, Marc DELCOURT, Philippe MARLIÈRE
  • Publication number: 20160326500
    Abstract: Described are 3-hydroxyisovalerate (HIV) synthase variants having improved activity in converting acetone and a compound which provides an activated acetyl group into 3-hydroxyisovalerate (HIV). Moreover, described are in particular methods for the production of 3-hydoxyisovalerate and methods for the production of isobutene from acetone utilizing the HIV synthase variants of the present invention.
    Type: Application
    Filed: December 17, 2014
    Publication date: November 10, 2016
    Inventors: Philippe Marliere, Marc Delcourt, Sabine Mazaleyrat, Jean-Baptiste BARBAROUX
  • Publication number: 20160186161
    Abstract: Described are alkenol dehydratase variants having improved activity in catalyzing the conversion of a compound corresponding to the general formula CnH2nO into CnH2n-2+H2O with 3<n<7. In particular, described are alkenol dehydratase variants having, e.g., an improved activity in converting but-2-en-1-ol (crotyl alcohol) into 1,3 butadiene and/or an improved activity in converting but-3-en-2-ol into 1,3 butadiene and/or an improved activity in converting 3-methylbut-2-en-1-ol (prenol) or 3-methylbut-3-en-2-ol (isoprenol) into isoprene and/or an improved activity in converting 2,3-dimethyl-but-2-en-1-ol into dimethyl-butadiene.
    Type: Application
    Filed: May 16, 2014
    Publication date: June 30, 2016
    Inventors: Philippe Marliere, Marc Delcourt, Sabine Mazaleyrat
  • Publication number: 20160160204
    Abstract: Described are mevalonate diphosphate decarboxylase variants having improved activity in converting 3-phosphonoxyisovalerate into isobutene. Such variants can be employed in processes for biologically producing isobutene from 3-hydroxyisovalerate or from 3-hydroxy-3-methylbutyrate into isobutene, for biologically producing isoprenol from mevalonate or from mevalonate-3-phosphate or for biologically producing 1,3-butadiene from 3-hydroxypent-4-enoate or from 3-phosphonoxypent-4-enoate. Also described is an enzyme which is characterized in that it is capable of converting 3-phosphonoxyisovalerate into isobutene with a kcat of more than 0.1 s?1.
    Type: Application
    Filed: July 9, 2014
    Publication date: June 9, 2016
    Inventors: Sabine MAZALEYRAT, Marc DELCOURT, Maria ANISSIMOVA, Philippe MARLIERE